⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 6, 2025

Supplementary Fig. S2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy

Zhijun Zhou Yang Cai Hao Yuan Qun Chen Sophia W. Zhao Jingxuan Yang Mingyang Liu Alex X. Arreola Yu Ren Chao Xu Lacey R. McNally Michael S. Bronze Courtney W. Houchen Kuirong Jiang Wei R. Chen Yuqing Zhang Min Li

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: Ferroptosis levels are correlated with progression-free survival in the Van-Allen and Lauss cohorts.
KEY EVIDENCE: Higher ferroptosis levels may predict better treatment outcomes in cancer immunotherapy patients.
APPROACH: The study analyzed patient data from two cohorts to assess the relationship between ferroptosis and survival.
SIGNIFICANCE: Understanding ferroptosis as a biomarker may enhance patient treatment strategies in cancer immunotherapy.

Implication

Analysis shows ferroptosis levels correlate with progression-free survival in patients, indicating its potential as a biomarker.

Abstract

Supplementary Fig. S2. Progression-Free Survival of patients in Van-Allen cohort and Lauss cohort based on ferroptosis level.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhou et al. (2025) studied this question.

synapsesocial.com/papers/689a0fa0e6551bb0af8d17ec https://doi.org/10.1158/2767-9764.29836663

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Fig. S1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
2Supplementary Fig. S3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
3Supplementary Fig. S5 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
4Supplementary Fig. S4 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
5Supplementary Fig. S6 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025

Figure 1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
Figure 2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
Figure 3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025